Skip to content
Screener

Arbutus Biopharma Corporation ABUS Q2 2025 earnings

Reported August 6, 2025 · Before market open

Revenue$10.7MBeat by $9.1M
EPS$0.01Beat by $0.03
Revenue estimate$1.6M
EPS estimate-$0.02

Next report

Nov 16, 2026 (in a month)
Revenue estimate$1.0M
EPS estimate-$0.02

Financials

Q2 2025

Income statement

See full
Revenue$10.7M+522%
Operating income$1.5M+107%
Net income$2.5M+113%
EPS (diluted)$0.01+109%

Balance sheet

See full
Cash & equivalents$37.4M-40.4%
Total debt$1.1M-31.8%
Total equity$83.0M-32.2%
Total assets$103.3M-35.5%

Cash flow

See full
Operating cash flow-$15.7M-8.6%
CapEx--100%
Free cash flow-$15.7M-8.6%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$645.45M+10.7%
Enterprise value$609.12M+16.7%
P/S41.9×-16.1×

Profitability

See full
Operating margin-386.5%-134pp
Net margin-351.9%-124pp
FCF margin-391%-123pp

Returns & leverage

See full
Return on equity-52.8%-5.6pp
Debt / equity0×0.0×
Current ratio20.5×+14.0×

Segments

By product

See full
Collaborations and licenses$10.2M—
Revenue from collaborations and licenses$9.6M+1,399%
Non-cash royalty revenue$526.0K-7.9%

By segment

See full
Reportable Segment$10.7M+522%

FAQ

When did Arbutus Biopharma Corporation report Q2 2025 earnings?
Arbutus Biopharma Corporation (ABUS) reported Q2 2025 earnings on August 6, 2025 before market open.
What were Arbutus Biopharma Corporation's Q2 2025 revenue and EPS?
Arbutus Biopharma Corporation reported revenue of $10.7M and eps of $0.01 for Q2 2025.
Did Arbutus Biopharma Corporation beat estimates in Q2 2025?
Revenue beat the consensus estimate of $1.6M by $9.1M. EPS beat the consensus estimate of $-0.02 by $0.03.
How did Arbutus Biopharma Corporation's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 522.2% from $1.7M a year earlier.
Where can I find Arbutus Biopharma Corporation's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001171843-25-005076) and the 10-Q periodic report (0001447028-25-000115) directly on SEC EDGAR. The filing index links above go to sec.gov.